Literature DB >> 28732235

Medication takeovers: Covert druggings and behavioral control in Alzheimer's.

Brandon Berry1, Ester Carolina Apesoa-Varano2.   

Abstract

Older adults consume the most prescription medication in the U.S. For those who develop Alzheimer's disease, risk of medication misuse increases with the progression of the disease. Family members commonly intervene to lessen risks by taking over the management and administering of a medication regimen. Despite the potential for grave harm around the misuse of powerful drugs, few studies provide insight into the household social context of medication use for this disease. Drawing on 60 in-depth interviews conducted in four waves over 2.5 years, this study investigates how family members administered prescription and over-the-counter medications to elders with Alzheimer's. The findings detail how family members initially created and enacted the role of proxy-administrator to avoid self-administration errors and then expanded the role to manage disruptive behaviors. During this process, family members perceived themselves as working in partnership with doctors, especially in the effort to craft a regimen that controlled the affected individual's mood and sleep/wake cycle. The paper concludes by discussing the implications that family members used medications to improve conformity to a preferred household social order. The study offers conceptual advances in understanding 1) the process of proxy-administration in Alzheimer's care and 2) the role of proxy-administrators in the medicalization of deviant behavior.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Caregiving; Conflict; Interaction; Medicalization; Medication use; Social control; US

Mesh:

Substances:

Year:  2017        PMID: 28732235     DOI: 10.1016/j.socscimed.2017.07.003

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  3 in total

1.  "I know best:" women caring for kin with dementia.

Authors:  Ester Carolina Apesoa-Varano
Journal:  Soc Sci Med       Date:  2020-05-05       Impact factor: 4.634

Review 2.  Patient safety in marginalised groups: a narrative scoping review.

Authors:  Sudeh Cheraghi-Sohi; Maria Panagioti; Gavin Daker-White; Sally Giles; Lisa Riste; Sue Kirk; Bie Nio Ong; Aaron Poppleton; Stephen Campbell; Caroline Sanders
Journal:  Int J Equity Health       Date:  2020-02-12

3.  Differences in treatment for Alzheimer's disease between urban and rural areas in China.

Authors:  Bei Li; Dejun Liu; Qiaoqin Wan; Can Sheng; Xiting Wang; Fangda Leng; Qing Peng; Ting Wang; Ailian Du; Feiqi Zhu; Dunzhu Mima; Huali Wang; Hengge Xie; Zhaoxia Wang; Haiqiang Jin; Yongan Sun
Journal:  Front Neurol       Date:  2022-09-29       Impact factor: 4.086

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.